tiprankstipranks
Trending News
More News >
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
:GPCR
US Market

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership - Who Owns Structure Therapeutics, Inc. Sponsored ADR?

Compare
990 Followers

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview

11.71%35.93%47.13%1.06%4.17%
11.71% Insiders
47.13% Other Institutional Investors
1.06% ETFs
4.17% Public Companies and
Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 84.12% of the company’s stock is owned by Institutional Investors, 11.71% is owned by Insiders, and 4.17% is owned by Public Companies and Individual Investors.
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 83.05% of the company’s stock is owned by Institutional Investors, 11.71% is owned by Insiders, and 1.06% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 05, 2024
xxxxxxxxxxxxx
$5600988

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$28042
Dec 31, 2024
xxxxxxxxxxxxx
$359611
Dec 31, 2024
xxxxxxxxxxxxx
$2031288
Dec 31, 2024
xxxxxxxxxxxxx
$2220368

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,436,286Institution7.74%83,845,805
4,249,142Institution7.41%80,308,784
2,847,885Insider4.97%53,825,027
2,688,264Insider4.69%50,808,190
2,057,410Institution3.59%38,885,049
1,517,418Institution2.65%28,679,200
1,484,467Institution2.59%28,056,426
1,457,752Institution2.54%27,551,513
1,115,559Institution1.95%21,084,065
929,176Institution1.62%17,561,426

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,436,286Institution7.74%83,845,805
4,249,142Institution7.41%80,308,784
1,484,467Institution2.59%28,056,426
1,457,752Institution2.54%27,551,513
1,115,559Institution1.95%21,084,065
929,176Institution1.62%17,561,426
740,102Institution1.29%13,987,928
678,434Institution1.18%12,822,403
582,447Institution1.02%11,008,248
515,429Institution0.90%9,741,608

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
245,180Institution0.43%4,633,902
79,926Institution0.14%1,514,598
47,914Institution0.08%1,299,428
43,380Institution0.08%819,882
38,249Institution0.07%724,819
27,816Institution0.05%527,113
21,380Institution0.04%405,151
16,561Institution0.03%393,324
15,000Institution0.03%585,063
12,876Institution0.02%243,356

FAQ

Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately 47.13% of the company's stock is held by institutional investors, 11.71% is held by insiders, and 4.17% is held by retail investors.
    What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 47.13% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
      What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 4.17% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
        Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
        SMALLCAP World Fund Inc owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis